Dronedarone

Back to search

Molecule Structure

Scientific Name

Dronedarone

Description of the Drug

Dronedarone is an antiarrhythmic agent used in the reduce the risk of hospitalization in patients with paroxysmal or persistent atrial fibrillation.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04855

Brand Name(s)

Not Available

Company Owner(s)

Sanofi Aventis Us Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 SINGLE PROTEIN BLOCKER CHEMBL1250417
Inward rectifier potassium channel 2 SINGLE PROTEIN BLOCKER CHEMBL1914276
Voltage-gated L-type calcium channel PROTEIN FAMILY BLOCKER CHEMBL2095229
Sodium channel alpha subunit PROTEIN FAMILY BLOCKER CHEMBL2331043

Unichem Links

SureChEMBL SCHEMBL110363
Human Metabolome Database HMDB0251621
DrugBank DB04855
PubChem: Thomson Pharma 14861729
PubChem 208898
Mcule MCULE-5052395136
LINCS LSM-45428
Nikkaji J1.055.653H
BindingDB 50151864
EPA CompTox Dashboard DTXSID3048653
DrugCentral 4112
ChemicalBook CB11117179
Guide to Pharmacology 7465
rxnorm DRONEDARONE HYDROCHLORIDE MULTAQ DRONEDARONE
ChEBI 50659
ZINC ZINC000049933061